Member Info for KingHomerJ

A person spending time posting on a forum that they are not invested in.......Very very very strange behaviour.

Who cant answer any questions presented to them...

I wonder where you will be when the Biostats contracts drop?

Again,

Do you know the cash burn….NO

Again, The accounts don’t take into account the 3 contracts won since around £150k

You are also ignoring the fact that the contracted revenue already is on par with the whole of last years total revenue….after 3 months of this financial year

So are you stating PYC will deliver no contracts up until the end of June 2026….

Like I said before I think you need a better understanding of the company and the space it’s working in…..

Check out weatherdens….

We are all here to make money…..your hostility and short term understanding is irrelevant….

Wait for the Biostats contracts….guess you won’t be seen here then.

Good Luck

Laura,

Last years Revenue was £834k

This FY starting July 1st 2025 contracted revenue on books for FY ending June 2026 announce was £654k we have had 2 further contracts since then and a follow on contract - One contract being £98.6k One unknown and the follow on contract of 38k which would total £790,600 plus the unknown contract value.

On the £790k thats 43k away from beating last years revenue to date (This doesn't include the unknown value of the contract) which I'm sure based on the length is more than 43k

Also contract revenue into 2027

£700k Cash & £790k (Plus one unknown contract ) BOB in the first 3 months of this financial year....

The Dosing tool will take time which is granted - however at this MC there is definitely significant head room for a large rerate and very very very likely to Multibag

id suggest people look at the weatherdens links

Best presentation to date….with a very clear direction with levels of confidence.

The company is very clearly focusing on revenue generation and profitability…

Has a great cash balance which is half the current MC

Highest revenue contracted into 2026 & 2027

I confidently state I’m sure we will start a cycle of positive contracted news flow…and clearly Biostats will generate significant amounts of revenue….

All while we wait for DoseMerx, NHS Blackpool, Betond Blood and Weatherdens updates…..

Be the same type of person that goes on forums pumping oil company’s that run at huge losses with constant raises basis on “seismic data” knowing it’s always 50/50 regardless of strike rates etc / commerciality. (LOL)

I’d suggest they probably go do some research, read some books, get an understanding of the space & sector.

Not even gonna bother moving forward…waste of time….

You also forgot to mention that the Biostats recruitment as per 1st July to which we have a contract which is double the salary…

You have no knowledge of this company and no scientific basis to understand the business as a whole.

ATB

Have you added the contract awards since June 2025 in your calculation….. ok no.

Again…..I’ll ask you do you know the cash burn and runaway…..No you don’t.

Am I correct in stating and do the accounts point to the fact there the company has cash until Q4 2026 based on June 2025 without any further contracts.

We have already got 2….

Wait for the Biostats Contract(s) xxxxx

You don’t know this company or its sector…. You are frankly talking utter nonsense….

Correct- without taking into account future & current contracts.

Just CASH…..

Just wait for the next biostatistics contract…. As mentioned previously & by the company with will generate the same in not more than the VT platform effectively doubling revenue….

More like £700k cash as trade debtors was £ 245,721

Like I’ve been saying cash until Q4 2026 based on cash at the end of June 2025 - taking into account Zero contracts between now and then which is impossible

We have already secured 2 with Numab a Billion £ Company…..

Trout….this is based on current contracted revenue from June 2025….

So what you are saying is that PYC will generate no further contracts or revenue until June 2026 (Two of which we have already won with Numab - as per account)

Therefore the revenue from these two contracts alone are already higher than the accounts announced today which are historical figures….

Trout….You look very very silly about now…..

As stated we have cash until Q4 2026

Based on cash position and contracts won from June 2025 - therefore cash IF teh company didn’t get any further contracts between June 2025 and Q4 2026

Firstly that’s never going to happen and we have won contracts since June this year..

i will ask you again for the 5th time in 2 months.

Do you know the cash burn….No…….

GL

So what you are saying is that…PYC hasn’t / won’t get any more contracts until June next year….and all the forthcoming news on the dosing tool, Dosemerx commercialisation, bio stats & informatics etc won’t happen.

Bearing in mind we have already won more contracts on these numbers as this was last years accounts.

Jarri….You admittedly got burnt here….just move on…

Amateur…

As stated the company has enough cash until Q4 2026 based on current contracted revenue…. See below…..there is a lot of head room for a huge rerate here now……..

As at 30 June 2025 the Company held cash and cash equivalents of £461,242 (2024: £191,072), which are managed under a Board investment policy that prioritises low-risk cash or cash-equivalent investments to safeguard the principal, and trade debtors of £245,721 (2024: £102,510). Together with anticipated invoicing from contracted revenue of £594,000, these resources are projected to cover the majority of budgeted expenses for the year ending 30 June 2026.

Nor the distant future

I think the new recruits experience as stated on the website is evident PYC have / will be looking at future work away from oncology…..

Lets see if 0.56 Breaks....If it does should move Sharpley

Burt....Absolutely agree....

Hope you saw my post yesterday with the endless amounts of news that should be coming....As you say it only takes ONE...

I mean a 200k contract in itself would do 200% regardless of the rest

They will be a company update after results as per…..which as always will be forward looking….

When 0.56 breaks there is a lot of head room until 0.89

Results also Next week...

This exactly burt….at its previous VT consultancy - needs about about 200k to break even with zero debt.

This isn’t including the new revenue arms to the business,

Biostats

Bioformatics

ADC’s

All of which can generate million in revenue and can all

Be intertwined in long term projects from Phase 1-3 and in Human Trials

This also doesn’t include the current ongoing NHS trial at Blackpool Teaching Hospital - with beyond bloods

Or the DoseMerx agreement for the pathway to commercialisation of the software tool.

As previous stated current Cash from December and raise early 2025 plus revenue - cash burn is minimal and company has cash till Q4 2026